✦ LIBER ✦

Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial

✍ Scribed by John A. Olson Jr; G. Thomas Budd; Lisa A. Carey; Lyndsay A. Harris; Laura J. Esserman; Gini F. Fleming; Paul K. Marcom; George S. Leight Jr; Therese Giuntoli; Paul Commean; Kyongtae Bae; Jingqin Luo; Matthew J. Ellis

Book ID: 113679056
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 569 KB
Volume: 208
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2009.01.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors associated with surgical managem

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

✍ Criscitiello, C.; Azim, H. A.; Agbor-tarh, D.; de Azambuja, E.; Piccart, M.; Bas 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 96 KB

A randomized phase II trial of platinum

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

✍ E. Alba, J. I. Chacon, A. Lluch, A. Anton, L. Estevez, B. Cirauqui, E. Carrasco, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 254 KB

Neoadjuvant capecitabine chemoradiation

Neoadjuvant capecitabine chemoradiation (X-RT) for patients (pts) with locally advanced breast cancer (LABC) failing anthracycline-based neoadjuvant therapy: findings from a prospective phase II trial

✍ M.D.F. Gaui; Amorim; R. Arcuri; G. Pereira; D. Moreira; C. Djahjah; N. Spector 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Multicenter Phase II Trial of Neoadjuvan

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

✍ Glück, S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Letter to the editor on 'Factors associa

Letter to the editor on 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial'

✍ Barry, P. A.; Schiavon, G.; MacNeill, F. A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 126 KB